NCT00125749View on ClinicalTrials.gov

Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
MelanomaNeoplasm Metastasis
Interventions
BIOLOGICAL

Dendritic cell vaccination

Autologous Dendritic Cells Derived from PBMC, Cultured with Cytokines, Pulsed Ex Vivo with Irradiated Allogeneic (Colo 829) Melanoma Cells

Trial Locations (1)

75246

Mary Crowley Medical Research Center: Baylor University Medical Center, Dallas

Sponsors

Collaborators (1)

ODC Therapy
All Listed Sponsors
collaborator

Mary Crowley Medical Research Center

OTHER

collaborator

ODC Therapy

UNKNOWN

lead

Baylor Research Institute

OTHER